The Care for America's Aging Study: Home Health Aide Training for Dementia
This study, called "The Care for America's Aging Study," is looking at whether special training for home health aides can help people with cognitive impairment (problems with thinking, remembering, and learning) or dementia. The training, called "enhanced home health aide training in dementia and dementia-related behaviors," lasts 8 hours over two days. Researchers want to see if this training improves behavioral symptoms (like agitation or wandering) in older adults with dementia and their overall quality of life, as well as the quality of life for their care partners. You might be able to join if you are 60 or older, are a patient in the Mass General Brigham healthcare system, have mild to moderate cognitive impairment or dementia, and your discharge plan includes home care services. You also need to be able to read English. The study aims to enroll 120 people. The current status of the study is unclear.
- Study design
- This is an interventional pilot study that will randomly assign participants to different groups to see the effects of the training. It plans to enroll 120 participants.
- What's involved
- The study will measure your neuropsychiatric symptoms and global health at 6 months. It involves enhanced home health aide training for 8 hours over two days.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 6 months after the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Care for America's Aging Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Olivia I Okereke, MD, MS · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Neuropsychiatric Inventory-Questionnaire6 Months
The Neuropsychiatric Inventory-Questionnaire (NPI-Q) is a measure of neuropsychiatric symptoms which is completed by caregivers about their patient partners. The questionnaire aims to assess both the presence of symptoms and their severity. The score range is 0-36 points, where higher scores indicate greater severity of symptoms.
- Patient-Reported Outcomes Measurement Information System Global Health, 10-item6 months
The Patient-Reported Outcomes Measurement Information System Global Health 10-item (PROMIS-10) measures global health-related quality of life (hrQOL) based on physical, mental, and social functioning. The PROMIS-10 uses a T-score metric in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population; higher scores on the T-score metric indicate higher levels of the measured concept - in this case, higher global health-related quality of life.